Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks

ClinicalTrials.gov ID: NCT00700622

Public ClinicalTrials.gov record NCT00700622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase3, Multi-Center, Open-Label, Randomized, Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Insulin Inhalation Powder in Combination With Lantus® Versus Humalog® in Combination With Lantus® in Subjects With Type 1 Diabetes Mellitus Over a 16-Week Treatment Period

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to demonstrate that TI® Inhalation Powder combined with Lantus® is as effective as Humalog® combined with Lantus® on HbA1c.

Study identification

NCT ID
NCT00700622
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mannkind Corporation
Industry
Enrollment
130 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2008 (Type not available)
Primary completion
Nov 2009 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Oct 16, 2014

2008 – 2010

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
Diabetes/Lipid Management and Research Center Huntington Beach California 92648 —
The Whittier Institute for Diabetes Clinical Trials La Jolla California 92037 —
Dorothy L & James E Frank Diabetes Research Institute San Mateo California 94401 —
Barbara Davis Center for Diabetes Young Adult Clinic Aurora Colorado 80045 —
University of Miami Diabetes Research Institute Miami Florida 33136 —
University of Miami School of Medicine Miami Florida 33136 —
Atlanta Diabetes Associates Atlanta Georgia 30309 —
Tulane University Health Sciences Center New Orleans Louisiana 70112-2699 —
Washington University School of Medicine St Louis Missouri 63110 —
Deaconess Billings Clinic Research Center Billings Montana 59101 —
Mountain Diabetes & Endocrine Center Asheville North Carolina 28803 —
Endocrine Research Physicians East PA Greenville North Carolina 27834 —
Your Diabetes Endocrine Nutrition Group, Inc. Mentor Ohio 44060 —
OHSU Diabetes Center Research Oregon Health & Science University Portland Oregon 97239 —
AM Diabetes and Endocrinology Center Barrtlett Tennessee 38133 —
Dallas Diabetes & Endocrine Center Dallas Texas 75230 —
Baylor Endocrine Center Dallas Texas 75246 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Diabetes Research Center -Fletcher Allen Health Care South Burlington Vermont 05403 —
Diabetes Care Center Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00700622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2014 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00700622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →